Rationale and objectives Relapse to old unhealthy eating habits while dieting is often provoked by stress or acute exposure to palatable foods. We adapted a rat reinstatement model, which is used to study drug relapse, to study mechanisms of relapse to palatable food seeking induced by food-pellet priming (non-contingent exposure to a small amount of food pellets) or injections of yohimbine (an alpha-2 adrenoceptor antagonist that causes stress-like responses in humans and non-humans). Here, we assessed the predictive validity of the food reinstatement model by studying the effects of fenfluramine, a serotonin releaser with known anorectic effects, on reinstatement of food seeking. Methods We trained food-restricted female and male rats to lever-press for 45-mg food pellets (3-h sessions) and first assessed the effect of fenfluramine (0.75, 1.5, and 3.0 mg/kg, i.p.) on food-reinforced responding. Subsequently, we extinguished the food-reinforced responding and tested the effect of fenfluramine (1.5 and 3.0 mg/kg) on reinstatement of food seeking induced by yohimbine injections (2 mg/kg, i.p.) or pellet priming (four non-contingent pellets). Results Fenfluramine decreased yohimbine-and pelletpriming-induced reinstatement. As expected, fenfluramine also decreased food-reinforced responding, but a control condition in which we assessed fenfluramine's effect on high-rate operant responding indicated that the drug's effect on reinstatement was not due to performance deficits.
Many people attempt to control their food consumption by dieting, but they typically relapse to their old unhealthy eating habits within a few months (Kramer et al. 1989; Peterson and Mitchell 1999; Skender et al. 1996) . There is evidence that this relapse is often triggered by exposure to palatable foods, exposure to food-associated cues, or exposure to stress (Byrne et al. 2003; Gorin et al. 2004; Grilo et al. 1989; Herman and Polivy 1975; Kayman et al. 1990; McGuire et al. 1999; Polivy and Herman 1999; Torres and Nowson 2007) .
Despite the established pattern of relapse to unhealthy eating habits during dieting in humans, the mechanisms of this phenomenon have rarely been studied in animal models (Nair et al. 2009b ). To address this issue, we and others adapted a rat reinstatement model, commonly used to study relapse to abused drugs (See 2002; Self and Nestler 1998; Shaham et al. 2003) , to investigate mechanisms of relapse to food seeking (Nair et al. 2009a ). In this model, relapse in food-restricted (dieting) rats can be triggered by acute exposure to small amounts of food (herein referred to as "pellet priming") or food-associated cues (De Vries et al. 2005; Ghitza et al. 2007) or systemic injections of the pharmacological stressor yohimbine (Ghitza et al. 2006; Nair et al. 2011; Richards et al. 2008) . Yohimbine is an alpha-2 adrenoceptor antagonist that induces stress-and anxiety-like states in both humans and laboratory animals (Bremner et al. 1996a; Holmberg and Gershon 1961; Lang and Gershon 1963) .
A key feature of the food reinstatement model is that the rats are maintained on mild food restriction conditions that are commonly used in many drug self-administration studies (Belin et al. 2009; Picciotto and Corrigall 2002) and studies on the neurobiological mechanisms of appetitive learning and motivation (Balleine and Dickinson 1998; Kelley and Berridge 2002) . The chronic diet condition was chosen because human studies suggest that dietary restraint leads to increased vulnerability to stress-and food-cueinduced food craving and relapse to palatable food intake (Herman and Polivy 1975; Polivy et al. 2005; Polivy and Herman 1999) .
Over the last decade, the widespread use of the reinstatement model has led to a debate about the validity of this procedure as an animal model of drug relapse in humans Fuchs et al. 1998; Katz and Higgins 2003) . The recent use of the reinstatement model to study relapse to food seeking has also raised the question whether findings from studies using this model relate to mechanisms of relapse to unhealthy eating habits during dieting (Nair et al. 2009a) .
We sought to test the predictive validity of the reinstatement model by examining the effect of fenfluramine on reinstatement of food seeking in food-restricted (a dieting condition) rats. In the psychiatry literature, predictive validity typically refers to the ability of an animal model to identify drugs with potential therapeutic value (Geyer and Markou 1995; Markou et al. 1993; Sarter and Bruno 2002; Willner 1984) . The serotonin releaser fenfluramine is a highly effective anorectic agent in both laboratory animals and humans (Davis and Faulds 1996; McGuirk et al. 1991; Rowland and Carleton 1985) that was removed from clinical use due to adverse health effects (Rothman and Baumann 2002) . While in previous food reinstatement studies we only used male rats (Ghitza et al. 2006; Ghitza et al. 2007; Nair et al. 2009b; Nair et al. 2011 ), here we studied female rats in addition to male rats because the proportion of women who use dietary supplements and seek dietary treatment is more than twice that of men (Davy et al. 2006; Pillitteri et al. 2008) . Finally, we assessed the effect of fenfluramine on ongoing food-reinforced responding for food pellets under two training conditions-operant training sessions every day or every other day-that lead to moderate or high response rates, respectively. The assessment of the first training condition (every day) was performed in order to compare the effect of fenfluramine on food-reinforced responding to its effect on reinstatement of food seeking. The assessment of the second training condition (every other day) was performed in order to rule out the possibility that fenfluramine's inhibitory effect on reinstatement of food seeking is due to performance deficits.
Materials and methods

Subjects and apparatus
Long-Evans female (n=24; NIDA breeding program; 200-340 g) and male (n=24; Charles River, 300-350 g) were maintained on a reverse 12-h:12-h light:dark cycle (lights off at 8:00 a.m.). Two female rats were excluded from the study due to poor health or unreliable food-reinforced responding during training. The rats were weighed daily. The female and male rats were food-restricted to 9-11 or 15-17 g/day, respectively, of standard rat chow (about 55-65% of their daily food intake) during the training phase and to 12-14 or 18-22 g/day, respectively, to maintain relatively stable body weight during the extinction and reinstatement test phases. The daily rat chow ration was given after the daily sessions. Experiments were conducted in standard self-administration chambers (Med Associates, Georgia, VT). Each chamber had two levers 9 cm above the floor, but only one lever (the "active," retractable lever) activated the pellet dispenser, which delivered 45-mg food pellets containing 12.7% fat, 66.7% carbohydrate, and 20.6% protein (Catalogue # 1811155, TestDiet, Richmond, IN) . This pellet type was chosen based on pellet preference tests in food-restricted female rats, using six pellet types (obtained from TestDiet and Bioserv) with different compositions of fat (0% to 35%) and carbohydrate (45% to 91% [sugar pellets]) and different flavors (no flavor, banana, chocolate, and grape), in which it was determined to be the most preferred pellet. All procedures followed the guidelines outlined in the "Principles of laboratory animal care" (NIH publication no. 85-23). Efforts were made to minimize the number of rats used and their suffering.
Drugs
Yohimbine hydrochloride, purchased from Sigma (St. Louis, MO), was dissolved in sterile water and injected in a volume of 0.5 ml/kg, i.p. The yohimbine dose is based on previous studies in male rats (Ghitza et al. 2007; Nair et al. 2009b; Nair et al. 2008 ) and a pilot study with female rats. (±)-Fenfluramine HCl (formula weight=267.7), obtained from the NIDA IRP Pharmacy, was dissolved in distilled water (male rats every-day training dose-response testing) or sterile saline (all other test conditions) and injected in a volume of 1 ml/kg, i.p. Fenfluramine doses are based on previous studies on the drug's effect on food intake (Burton et al. 1981; Rivera and Eckel 2005) and reinstatement of cocaine seeking (Burmeister et al. 2003) .
Procedures
Both male and female rats were run in two groups (morning, afternoon) of n=11-12 rats that were repeatedly tested. The experimental procedure included four phases: (1) initial training for food-reinforced responding, (2) determination of fenfluramine's effect on ongoing foodreinforced responding (morning groups) or continuation of training (afternoon groups), (3) extinction of the foodreinforced responding, and (4) repeated tests for fenfluramine's effect on yohimbine-and pellet-priming-induced reinstatement under extinction conditions. Following the test phase, in the morning groups, we also assessed fenfluramine's effect on ongoing food-reinforced responding during sessions performed every other day (see below). During all phases, the sessions started 30 min after rats were placed in the self-administration chambers: 8:30 a.m. for the morning groups and 12:30 p.m. for the afternoon groups.
Initial training for operant food-reinforced responding
We gave all rats 3-h daily sessions of "autoshaping" for 3 days during which pellets were administered non-contingently every 5 min into a receptacle located near the retracted active lever. Pellet delivery was accompanied by a compound 5-s tone (2,900 Hz) plus light (7.5-W white light cue located above the active lever). Subsequently, we trained the rats to self-administer the pellets on a fixed-ratio-1, 20-s timeout reinforcement schedule for five daily 3-h training sessions. At the start of each session, the red houselight was turned on, and the active lever was extended. Reinforced active-lever presses resulted in the delivery of one pellet, accompanied by the compound 5-s tone-light cue. Active-lever presses during the 20-s timeout or presses on the inactive lever had no programmed consequences. Rats were housed in the animal facility and transferred to the self-administration chambers prior to the training sessions, and returned to the facility at the end of the 3-h sessions.
Extinction of food-reinforced responding
The rats were given 13 daily 3-h extinction sessions. During the extinction phase, responses on the previously active lever led to tone-light cue presentations, but not pellet delivery.
Effect of fenfluramine on ongoing operant food-reinforced responding
Every-day training
After rats achieved stable levels of lever pressing for food pellets (training day 5), we used a within-subjects design to determine the effect of fenfluramine (0, 0.75, 1.5, and 3 mg/kg, i.p.; counterbalanced order) on ongoing food-reinforced responding. We injected the morning rats (n =11-12 per group) with vehicle or fenfluramine 30 min before the 3-h daily sessions. Half of the female rats were tested on days 6-9 of training and the other half on days 10-13; when not tested, the female rats were given a regular training session). The male rats were injected with fenfluramine every 48 h, with regular training sessions given in the intervening days. Concurrently, the afternoon rats (n=11-12 per group) underwent daily training sessions so that the total number of training sessions (with or without fenfluramine) was equal in both groups prior to the extinction phase.
Every-other-day retraining
Using the same experimental design described previously, we studied the effects of fenfluramine (0, 1.5, and 3 mg/kg, i.p.; counterbalanced) on ongoing food-reinforced responding after retraining the rats to lever-press for food pellets on an every-other-day schedule. We have added this experimental condition (which leads to high rate of responding, see Fig. 2 ) at the end of the reinstatement tests in order to rule out the possibility that fenfluramine's effects on reinstatement of food seeking are due to performance deficits. Following the reinstatement tests, we retrained 10 female and 12 male rats from the morning group to leverpress for food pellets in three training sessions conducted every other day, over 6 days. We then injected vehicle or fenfluramine every other day, 30 min before the 3-h sessions. The female and male rats received 9 or 16 g of regular food per day, respectively, in their home cages during the retraining days and the fenfluramine test days.
Effect of fenfluramine on yohimbine-and pellet-priminginduced reinstatement
We used a within-subjects design with the factors of Fenfluramine Dose (0, 1.5, and 3 mg/kg; counterbalanced order) and Yohimbine Dose (0 and 2 mg/kg; counterbalanced order) or Pellet Priming (zero and four pellets; counterbalanced order) to study the effects of fenfluramine on yohimbine-and pellet-priming-induced reinstatement of food seeking. During the tests for yohimbine-induced reinstatement, the rats received injections of saline (vehicle) or fenfluramine that were immediately followed by injections of water (vehicle) or yohimbine (2 mg/kg) 30 min before the start of the test sessions. During the tests for pellet-priming-induced reinstatement, the rats received injections of saline (vehicle) or fenfluramine 30 min before the start of the test sessions and received zero (no pellet) or four non-contingent pellets within 1 min after the start of the sessions. The rats were tested both for the effect of fenfluramine or its vehicle on yohimbine-or pellet-priminginduced reinstatement and for the effect of fenfluramine or its vehicle on baseline extinction responding (the yohimbine vehicle condition or the no pellet condition). The test sessions were performed every 48 h, with regular extinction sessions in the intervening days in which the rats were not injected with fenfluramine or yohimbine or exposed to pellet priming.
Statistical analyses
Data were analyzed using mixed-factor ANCOVAs in Statistica. The dependent measures for ongoing foodreinforced responding were the number of pellets earned, timeout responding (lever presses during the 20-s timeout after each pellet delivery), and food-cup entries (a common measure of food seeking in learning and memory studies (Balleine and Dickinson 1991; Holland 2008) ). The dependent measures during the extinction and reinstatement tests were the number of presses on the previously active lever and food-cup entries. In the statistical analyses of the reinstatement data, the baseline (zero pellet or yohimbine vehicle) extinction responding after fenfluramine vehicle (saline) injections is based on a mean of three sessions performed during early, middle, and late testing, and baseline extinction responding after injections of 1.5-or 3.0-mg/kg fenfluramine is based on two interspaced sessions during testing. Because yohimbine increased inactive-lever presses (Table 1) , a potential measure of nonspecific behavioral activation/suppression and/or response generalization (Shalev et al. 2002) , we used this measure as a covariate in all analyses. Thus, the ANCOVAs for assessing food-reinforced responding included the between-subjects factor of Sex (female and male), the within-subjects factor of Fenfluramine Dose (0, 0.75, 1.5, 3.0, mg/kg or 0, 1.5, and 3.0 mg/kg), and the covariate of inactive-lever presses. The ANCOVAs for assessing reinstatement of food seeking included the between-subjects factor of Sex, the withinsubjects factors of Fenfluramine Dose and Yohimbine Dose (0 and 2 mg/kg) or Pellet Priming (zero and four pellets), and the covariate of inactive-lever presses. One male and two female rats were excluded from the analysis of fenfluramine's effect on yohimbine-induced reinstatement because the number of presses on the inactive lever was more than three standard deviations higher than the group's mean. The factors used in the statistical analyses are described in the "Results" section. Significant interaction effects (p<0.05) in the different analyses were followed by post-hoc Tukey tests.
Results
The rats were initially trained to lever-press for food pellets for 5 days (3 h/day) and demonstrated reliable foodreinforced responding, but the time course of responding over days somewhat differed between the females versus the males (Fig. 1a) . The statistical analysis showed an interaction of Sex×Training Day for pellets and time-out responses (F 4,172 =7.5 and F 4,172 = 2.5, respectively, p values<0.05) but no main effect of Sex (p values>0.1). There was no main effect or interaction of Sex on food-cup entries (p values>0.1). During the extinction phase, activelever pressing and food-cup entries decreased over days, with a similar time course for the females and the males (Fig. 1b) . The statistical analysis showed a main effect of Extinction Session (p<0.01), but no effect of Sex or Sex× Extinction Session interaction for active-lever presses or food-cup entries (p values>0.1). During the training and extinction phases, the body weight of the female rats remained stable, while the body weight of the males increased during training and remained relatively stable during the extinction phase (Fig. 1c) .
Effect of fenfluramine on ongoing operant food-reinforced responding
Every-day training
Fenfluramine injections decreased pellet intake and timeout active-lever presses in both female and male rats, but decreased food-cup entries only in male rats (Fig. 2) . The statistical analyses for pellet intake and timeout active-lever presses showed significant effects of Fenfluramine Dose (F 3,63 =28.7 and F 3,63 =17.0, respectively, p<0.01) and Sex (F 1,21 =4.3 and F 1,21 =7.3, respectively, p<0.05), but no interaction (p>0.1). The statistical analyses for food-cup entries showed a significant effect of Fenfluramine Dose (F 3,63 =8.6, p< 0.01) and a significant Fenfluramine Dose×Sex interaction (F 3,63 =3.1, p<0.05), but no effect of Sex (p>0.1). Fenfluramine had no effect on inactive-lever responding, which was very low in all conditions (data not shown).
Every-other-day training
The rats were retrained after the reinstatement tests to leverpress for food pellets every other day. Under these conditions, which led to substantially higher response rates than in the every-day training condition, fenfluramine injections also decreased pellet intake and timeout activelever presses (effect of Fenfluramine Dose: F 2,38 =25.1 and F 2,38 =18.6, p<0.01, respectively) (Fig. 2) . There was no significant main effect of Sex or interaction of Sex× Fenfluramine Dose for either measure (all p>0.05), but as can be seen in Fig. 2 , the effect of the high fenfluramine dose (3 mg/kg) on pellet intake and timeout responding and the low fenfluramine dose for timeout responding was significant for males but not for females. The female rats made more food-cup entries than male rats (effect of Sex: F 1,19 =7.4, p<0.05), but there was no effect of Fenfluramine Dose or Sex×Fenfluramine dose (all p>0.05). Fenfluramine had no effect on inactive-lever responding, which was low in all conditions (data not shown).
Effect of fenfluramine on yohimbine-and pellet-priminginduced reinstatement
Fenfluramine attenuated yohimbine-and pellet-priminginduced reinstatement of active-lever presses in both males and females (Figs. 3 and 4) . Fenfluramine also attenuated yohimbine-induced reinstatement of food-cup entries in both males and females (Fig. 3 ), but had a weaker effect on pellet-priming-induced reinstatement of food-cup entries in both sexes (Fig. 4) . In both females and males, the higher dose of fenfluramine also somewhat decreased baseline active-lever extinction responding, but not food-cup entries (Figs. 3 and 4) . In the following analyses, an interaction between Fenfluramine Dose and Yohimbine Dose or Pellet Priming reflects a selective or preferential effect of fenfluramine on the dependent measure (active lever or food-cup entries) during the reinstatement condition (2-mg/kg yohimbine or 4 pellets) versus the baseline extinction condition (water injection or zero pellets). Finally, with an exception of some effect of time of day on yohimbineinduced reinstatement in female rats (lower responding in the afternoon group), lever presses and food-cup entries did not significantly differ between the rats tested in the morning versus the afternoon (data not shown); additionally, we did not observe habituation to the experimental manipulations over repeated testing (data not shown).
Yohimbine-lever presses
The analysis showed significant effects of Yohimbine Dose (F 1,40 =26.3, p<0.01), Fenfluramine Dose (F 2,80 = 11.6, p<0.01), and Fenfluramine Dose×Yohimbine Dose responses on the active lever (total lever presses minus pellets earned), food-cup entries, and inactive lever presses during the training sessions. Rats were trained on a fixed-ratio-1 (FR-1) 20-s timeout reinforcement schedule (n=22 females and 24 males). b Extinction of food-reinforced responding: mean±sem number of responses on the previously active lever, food-cup entries, and inactive lever presses. c Body weight: mean±sem body weights during the training and extinction phases. During the training phase, the female and male rats were maintained on 9-11 or 15-17 g/day, respectively, of regular chow food and were given 3-h access to food pellets every day. During the extinction sessions, food pellets were not available in the self-administration chambers, and the female and male rats were maintained on 12-14 or 18-22 g/day, respectively, of regular chow to maintain stable body weight (F 2,80 =5.4, p<0.01). There was no main effect or interaction with Sex.
Yohimbine-food-cup entries
The analysis showed significant effects of Sex (F 1,40 =4.4, p<0.05), Yohimbine Dose (F 1,40 =20.3, p<0.01), Fenfluramine Dose (F 2,80 =8.7, p<0.01), and Fenfluramine Dose× Yohimbine Dose (F 2,80 =7.0, p<0.01). The significant effect of Sex reflects overall higher food-cup entries in females than in males across the three fenfluramine dose conditions.
Pellet priming-lever presses
The analysis showed significant effects of Pellet Priming (F 1,43 =56.7, p<0.01), Fenfluramine Dose (F 2,86 =28.5, p< 0.01), and Fenfluramine Dose×Pellet Priming (F 2,86 =9.1, p<0.01). There was no main effect or interaction with Sex. responses on the active lever (total active-lever presses minus pellets earned), and c food-cup entries after fenfluramine injections under every-day training (n=12 females, n=12 males) or every-other-day retraining (n=10 females, n=12 males) conditions. Fenfluramine or vehicle was injected 30 min before the start of the test sessions. Different from the saline condition; *p<0.05
Every day training Every day training Every other day training Every other day training
Pellet priming-food-cup entries
The analysis showed significant effects of Pellet Priming (F 1,43 =71.8, p<0.01) and Fenfluramine Dose (F 2,86 =7.0, p< 0.01); no other effects or interactions were significant.
Discussion
We assessed the predictive validity of the food reinstatement model by determining the effect of fenfluramine, a serotonin releaser with known anorectic effects (Rowland and Carleton 1985) , on reinstatement of food seeking induced by the pharmacological stressor yohimbine or non-contingent pellet priming. In both males and females, fenfluramine decreased yohimbine-induced reinstatement of active-lever presses, the traditional measure of reward seeking in reinstatement studies (Stewart and de Wit 1987) . Fenfluramine also decreased yohimbine-induced reinstatement of food-cup entries (a secondary measure of oral reward seeking in reinstatement studies (Burattini et al. 2006; Le et al. 2011 ) and appetitive learning and motivation studies (Balleine and Dickinson 1991; Holland 2008; Kelley and Berridge 2002) ), but had a more modest effect on pellet-priming-induced food-cup entries. These data support the predictive validity of the food reinstatement procedure.
A main finding in our study is the overall lack of sex differences for either yohimbine-or pellet-priming-induced reinstatement or fenfluramine's effect on reinstatement of food seeking. The results for yohimbine-induced reinstatement are different from those demonstrating stronger yohimbine-induced reinstatement of cocaine seeking (Anker and Carroll 2010) or yohimbine-induced potentiation of cue-induced cocaine seeking (Feltenstein et al. 2011b) in female rats than in male rats. However, our findings are consistent with the report of lack of sex differences in yohimbine-induced reinstatement of nicotine seeking (Feltenstein et al. 2011a ). Feltenstein et al. (2011b) also reported a role of ovarian hormones/estrous cycle in Effect of fenfluramine on yohimbine-induced reinstatement of food seeking in female and male rats. Mean±sem number of a activelever presses and b food-cup entries in rats injected with saline (vehicle) or fenfluramine that were immediately followed by injections of water (vehicle) or yohimbine (2 mg/kg) 30 min before the start of the test sessions (n=20 females, n=23 males). Different from the saline condition; *p<0.05
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yohimbine-induced reinstatement of cocaine seeking. Here, we did not assess the ovarian hormones' role in reinstatement of food seeking, but it is unlikely that fluctuations in hormone levels confound data interpretation. We recently found that ovariectomy had a very modest effect on pellet-priming-induced reinstatement and no effect on yohimbine-induced reinstatement of food seeking. Additionally, both yohimbine-and pellet-priming-induced reinstatement were not influenced by the estrous cycle phase ).
There is evidence for sex differences in extinction responding (Kerstetter et al. 2008 ) and drug-priminginduced reinstatement of cocaine seeking (Carroll et al. 2004; Lynch 2006) . In contrast, we did not observe sex differences in either extinction responding or pelletpriming-induced reinstatement of food seeking. Thus, the type of the self-administered reward and the type of the reinstatement manipulation can determine whether sex and/or ovarian hormones will influence reinstatement of reward seeking.
The finding that fenfluramine decreased yohimbineinduced reinstatement of food seeking is in agreement with previous reports on the effect of fenfluramine or the SSRI fluoxetine on footshock-stress-induced reinstatement of alcohol seeking (Le et al. 2006; Le et al. 1999 ). These present and previous results suggest that increasing brain serotonin levels decreases reward seeking. This notion is supported by the finding that fenfluramine or fluoxetine decreases cue-induced cocaine seeking (Baker et al. 2001; Burmeister et al. 2003) . Conversely, local inhibition of median raphe serotonergic neurons reinstates alcohol seeking (Le et al. 2002) , and serotonin depletion increases cue-induced sucrose seeking .
In agreement with previous reports (Foltin and Fischman 1988; Taylor 1973; Willner et al. 1990 ), fenfluramine decreased food-maintained responding. In females, but not males, this effect was more reliable in the every-day training condition (which led to moderate response rates) than in the every-other-day training condition (which led to higher response rates). Unexpectedly, fenfluramine only minimally affected food-cup entries in both training conditions in females and the every-other-day condition in males. The reasons for fenfluramine's dissociable effects on lever presses versus food-cup entries during training for females (but not males), which were not observed during reinstatement testing, are unknown.
Methodological considerations
There are two main methodological issues that should be considered before concluding that fenfluramine's effect on reinstatement of food seeking reflects a decrease in the motivation to seek food. The first is that fenfluramine's effect is due to non-specific behavioral suppression; the second is that our repeated testing procedure confounds data interpretation. We discuss these issues in the following.
Non-specific behavioral suppression
The findings that the higher dose of fenfluramine (3 mg/kg) decreased baseline lever-pressing extinction responding (Fig. 4) and pellet-prime-(in females) and yohimbineinduced increases (in both sexes) in inactive-lever presses (Table 1) suggest that fenfluramine's effect on reinstatement and ongoing food-reinforced responding might be due to non-specific behavioral suppression. However, two lines of evidence indicate that this alternative interpretation is unlikely. First, in the assessment of food-reinforced responding, mean ± sem total number of active-lever responses (pellets earned+timeout responses per 3 h) after injections of the high fenfluramine dose (3 mg/kg) was either similar (every-day testing: females, 211±28; males, 201±20) or substantially higher (every-other-day testing: females, 1,027±153; males, 457±37) than the response rates during testing in the vehicle condition during the reinstatement tests (about 100 and 200 active-lever presses for pellet priming and yohimbine, respectively (Figs. 3 and 4) ). This difference suggests that fenfluramine's effect on reinstatement is not the result of lever-pressing impairments during testing after pretreatment with the drug. Additionally, as can be seen in Fig. 2 , the rats were capable of performing hundreds of food-cup entries in the every-day foodreinforced testing and 800 (in males) to over a thousand (in females) food-cup entries in the every-other-day testing after injections of the high fenfluramine dose (Fig. 2) . Again, these findings suggest that decreased lever responding and food-cup entries during the reinstatement tests are not due to fenfluramine-induced motor deficits.
Yohimbine modestly increased inactive-lever presses (Table 1) , a potential measure of non-directed activity and/or response generalization (Shalev et al. 2002) , and this effect was attenuated by fenfluramine. It is unlikely that yohimbine's effect on inactive-lever presses confound our data interpretation because both yohimbine's effect on activelever presses and fenfluramine's effect on yohimbine-induced reinstatement remained significant when inactive lever was used as a covariate (see "Results"). Additionally, there is no clear evidence that yohimbine increases general activity or operant responding. For example, previous studies showed that yohimbine either increased (Schroeder et al. 2003) or decreased (Chopin et al. 1986 ) locomotion and either increased (Sethy and Winter 1972) , did not change (Hughes et al. 1996) , or decreased (Munzar and Goldberg 1999) foodmaintained operant responding. Finally, yohimbine's effect on inactive-lever presses appeared stronger in males than in females (Table 1) . Whether this effect is reliable/reproducible is unknown because, in our previous studies with male rats (Ghitza et al. 2006; Ghitza et al. 2007; Nair et al. 2009b; Nair et al. 2008; Nair et al. 2011 ), yohimbine's effect on inactive-lever presses was much smaller than the effect that we observed here. More generally, while inactive-lever data are commonly used in self-administration and reinstatement studies, interpretation of such data is not straightforward (see (Shalev et al. 2002) ), and there is little evidence that responding on this lever is associated with activity levels in the self-administration chambers (Fowler et al. 2007 ).
Impact of repeated testing
Under our experimental procedure, the rats were tested repeatedly for both yohimbine-and pellet-priming-induced reinstatement under different doses of fenfluramine. A potential concern with this repeated measure experimental design is an order effect. However, for three reasons, it is unlikely that an order effect or development of tolerance to fenfluramine confound data interpretation. First, fenfluramine's inhibitory effect on reinstatement was similar in the AM groups (previously exposed to fenfluramine during initial training) and the previously fenfluramine-naïve PM groups (data not shown). Second, lever presses or food-cup entries were similar during early and late testing (data not shown). Third, in a repeated measure counterbalanced experimental design, an order effect may increase the variability across the experimental conditions (or increase the error variance), resulting in decreased power for detecting a given experimental effect, but will not introduce a systematic bias within a given experimental condition. Finally, we and others have used repeated testing in pharmacological studies on reinstatement of drug seeking and obtained reliable results (De Vries et al. 2002; de Wit and Stewart 1981; Fuchs et al. 2005; Self et al. 1996; Shaham et al. 1998; Spealman et al. 1999; Weiss et al. 2001 ).
The reinstatement procedure and predictive validity
The reinstatement procedure is widely used to study neurobiological mechanisms of drug relapse and to identify medications for relapse prevention (over 500 published papers since 2005). More recently, we and others have begun using this procedure to identify mechanisms underlying relapse to palatable food seeking during dieting (Nair et al. 2009a ). Yet, the predictive validity of the reinstatement procedure in its true sensemedications first identified in the animal model that later demonstrated clinical efficacy for relapse prevention-has not been established Katz and Higgins 2003) . Our data showing that fenfluramine attenuates yohimbine-and pellet-priming-induced reinstatement of food seeking support the "postdictive" validity of the food reinstatement procedure. Postdictive validity refers to a situation in which an effective medication in humans was subsequently demonstrated to be effective in the animal model (Goldstein and Simpson 2002; Nunnally and Bernstein 1994) .
Our results are in agreement with data from several studies in which approved medications for drug addiction were subsequently assessed in the reinstatement procedure. For example, relapse to alcohol use is modestly decreased by naltrexone (O'Malley et al. 1992; Volpicelli et al. 1992) or acamprosate (Sass et al. 1996; Whitworth et al. 1996) . In rats, these drugs decrease alcohol-priming-and cue-induced reinstatement of alcohol seeking (Bachteler et al. 2005; Burattini et al. 2006; Ciccocioppo et al. 2003; Le et al. 1999; Liu and Weiss 2002) , but see Heidbreder et al. (2007) for negative results for cue-induced reinstatement in mice. Additionally, buprenorphine and methadone maintenance are effective treatments for preventing relapse to heroin use in humans (Dole et al. 1966; Jasinski et al. 1978) . In rats, chronic delivery of these drugs after self-administration training decreases heroin-priming-induced reinstatement (Leri et al. 2004; Sorge et al. 2005) . Furthermore, varenicline is a recently FDA-approved effective medication for the treatment of nicotine addiction Oncken et al. 2006) . In rats, systemic injections of the drug decrease nicotine-priming-and nicotine-priming+ discrete-cue-induced reinstatement (O'Connor et al. 2010) ; varenicline, however, does not affect discrete-cue-induced reinstatement of nicotine seeking (O'Connor et al. 2010; Wouda et al. 2011) .
On the other hand, there are examples of effective medications for relapse prevention in humans, like bupropion (Hurt et al. 1997) , which reinstates rather than inhibits drug (nicotine) seeking in rats following acute injections (Liu et al. 2008 ). There are also examples of drugs that decrease reinstatement of drug (cocaine) seeking, like fluoxetine (Burmeister et al. 2003) , that do not demonstrate clinical efficacy (Grabowski et al. 1995) . Thus, like other animal models of psychiatric disorders (Geyer and Markou 1995; Sarter and Bruno 2002; Willner 1984) , the concordance between the effects of drugs in the reinstatement procedure and the human condition is not perfect.
Finally, an issue to consider in our study and other animal reinstatement studies is that, with a few exceptions (Amen et al. 2011; Reichel et al. 2011 ), drugs are typically tested for their acute effect on reinstatement, while in humans, drugs are given chronically (see Epstein et al. (2006) for a discussion of this issue and its implications for accounting for some differences between results from reinstatement studies and human clinical trials). Thus, a question for future research is whether fenfluramine would also decrease reinstatement of food seeking when administered chronically during the extinction and reinstatement phases. However, similarity in the drug treatment conditions between the animal model and the human condition, while preferable, is not a requirement for the animal model's predictive (or postdictive) validity (Sarter and Bruno 2002) . For example, in the forced-swim test, an animal model with established predictive validity for depression, drugs are tested for their acute or short-term (e.g., two injections in 24 h) effects on behavior (Porsolt 2000; Porsolt et al. 1978; Wong et al. 2000) .
Concluding remarks
We found that fenfluramine, an effective pharmacological treatment for excessive food intake in humans, decreased reinstatement of food seeking induced by the pharmacological stressor yohimbine and acute exposure to the palatable food in both female and male rats. These data support the predictive validity of the food reinstatement procedure. We hope that our findings will encourage feeding and addiction researchers to use this procedure to identify novel medications for prevention of relapse during dietary treatments.
